Fundraising FoxNorthern Light Venture Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.
BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US
Wenbin Jiang, Ph.D.(CEO and Chairman of the Board; co-founder)Wenbin Jiang(Executive Officer, Director)inMing Yan, Ph.D.(Chief Technology Officer; co-founder)Ming Yan(Executive Officer, Director)inJiecheng Zhang(Director)Allen Poirson(Director)
Co-investors3E Bioventures CapitalF-Prime CapitalRA Capital
Korean proptech operating a digital asset-backed securities platform for fractional commercial real estate investment; now winding down.
Changwhan Yea(Founder)Jaeyong Lee(Founder)Roman Pedan(Founder)
Co-investorsKakao VenturesMohari Ventures Limited (formerly, Ritastar)Allegion VenturesBoxGroupCerity Partners VenturesCiti Ventures+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.